2023 Q4 Form 10-Q Financial Statement
#000168285223000042 Filed on November 03, 2023
Income Statement
| Concept | 2023 Q4 | 2023 Q3 |
|---|---|---|
| Revenue | $2.811B | $1.831B |
| YoY Change | -44.71% | -45.57% |
| Cost Of Revenue | $929.0M | $2.241B |
| YoY Change | -51.56% | 103.73% |
| Gross Profit | $1.882B | -$410.0M |
| YoY Change | -40.56% | -118.11% |
| Gross Profit Margin | 66.95% | -22.39% |
| Selling, General & Admin | $470.0M | $442.0M |
| YoY Change | 25.33% | 58.99% |
| % of Gross Profit | 24.97% | |
| Research & Development | $1.406B | $1.160B |
| YoY Change | 16.1% | 41.46% |
| % of Gross Profit | 74.71% | |
| Depreciation & Amortization | $202.0M | $246.0M |
| YoY Change | 152.5% | 117.7% |
| % of Gross Profit | 10.73% | |
| Operating Expenses | $1.876B | $1.160B |
| YoY Change | 18.28% | 41.46% |
| Operating Profit | $6.000M | -$2.012B |
| YoY Change | -99.62% | -272.56% |
| Interest Expense | $103.0M | $58.00M |
| YoY Change | 37.33% | 26.09% |
| % of Operating Profit | 1716.67% | |
| Other Income/Expense, Net | -$39.00M | -$51.00M |
| YoY Change | 628.57% | |
| Pretax Income | $70.00M | -$1.958B |
| YoY Change | -95.77% | -260.89% |
| Income Tax | -$147.0M | $1.672B |
| % Of Pretax Income | -210.0% | |
| Net Earnings | $217.0M | -$3.630B |
| YoY Change | -85.19% | -448.03% |
| Net Earnings / Revenue | 7.72% | -198.25% |
| Basic Earnings Per Share | -$9.53 | |
| Diluted Earnings Per Share | $0.55 | -$9.53 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 381.3M shares | 380.6M shares |
| Diluted Shares Outstanding | 381.0M shares |
Balance Sheet
| Concept | 2023 Q4 | 2023 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $8.604B | $7.573B |
| YoY Change | -13.11% | -9.28% |
| Cash & Equivalents | $2.907B | $2.932B |
| Short-Term Investments | $5.697B | $4.641B |
| Other Short-Term Assets | $88.00M | $96.00M |
| YoY Change | 35.38% | 12.94% |
| Inventory | $202.0M | $487.0M |
| Prepaid Expenses | ||
| Receivables | $892.0M | $1.866B |
| Other Receivables | $0.00 | $280.0M |
| Total Short-Term Assets | $10.33B | $10.80B |
| YoY Change | -23.13% | -24.47% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $2.658B | $2.717B |
| YoY Change | 24.26% | 27.44% |
| Goodwill | $52.00M | $52.00M |
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $66.00M | $86.00M |
| YoY Change | -99.21% | -99.01% |
| Other Assets | $685.0M | $661.0M |
| YoY Change | -30.67% | 1639.47% |
| Total Long-Term Assets | $8.101B | $8.651B |
| YoY Change | -34.81% | -26.43% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $10.33B | $10.80B |
| Total Long-Term Assets | $8.101B | $8.651B |
| Total Assets | $18.43B | $19.45B |
| YoY Change | -28.74% | -25.35% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $520.0M | $494.0M |
| YoY Change | 6.78% | 49.7% |
| Accrued Expenses | $1.798B | $2.224B |
| YoY Change | -14.42% | 19.83% |
| Deferred Revenue | $568.0M | $1.372B |
| YoY Change | -72.13% | -65.72% |
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $0.00 | $150.0M |
| YoY Change | -100.0% | -33.04% |
| Total Short-Term Liabilities | $3.015B | $4.385B |
| YoY Change | -38.76% | -35.58% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $575.0M | $575.0M |
| YoY Change | -36.95% | -37.64% |
| Other Long-Term Liabilities | $256.0M | $172.0M |
| YoY Change | 89.63% | 112.35% |
| Total Long-Term Liabilities | $256.0M | $172.0M |
| YoY Change | 89.63% | 112.35% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $3.015B | $4.385B |
| Total Long-Term Liabilities | $256.0M | $172.0M |
| Total Liabilities | $4.572B | $5.995B |
| YoY Change | -32.12% | -25.66% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | $13.61B | $13.39B |
| YoY Change | -25.73% | -20.56% |
| Common Stock | $0.00 | $0.00 |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $13.85B | $13.46B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $18.43B | $19.45B |
| YoY Change | -28.74% | -25.35% |
Cashflow Statement
| Concept | 2023 Q4 | 2023 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $217.0M | -$3.630B |
| YoY Change | -85.19% | -448.03% |
| Depreciation, Depletion And Amortization | $202.0M | $246.0M |
| YoY Change | 152.5% | 117.7% |
| Cash From Operating Activities | $622.0M | -$1.600B |
| YoY Change | -62.58% | -734.92% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $220.0M | $140.0M |
| YoY Change | 139.13% | -257.3% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$318.0M | $929.0M |
| YoY Change | -66.74% | -10.15% |
| Cash From Investing Activities | -$538.0M | $789.0M |
| YoY Change | -48.66% | -16.51% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -109.0M | -58.00M |
| YoY Change | -75.11% | -94.43% |
| NET CHANGE | ||
| Cash From Operating Activities | 622.0M | -1.600B |
| Cash From Investing Activities | -538.0M | 789.0M |
| Cash From Financing Activities | -109.0M | -58.00M |
| Net Change In Cash | -25.00M | -869.0M |
| YoY Change | -114.2% | -657.05% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $622.0M | -$1.600B |
| Capital Expenditures | $220.0M | $140.0M |
| Free Cash Flow | $402.0M | -$1.740B |
| YoY Change | -74.39% | -610.26% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
0 | usd |
| CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
62000000 | usd |
| us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
0 | usd | |
| us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
133000000 | usd | |
| CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
|
0 | usd |
| us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
|
-8000000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
|
94000000 | usd | |
| CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
|
0 | usd |
| CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
|
12000000 | usd |
| us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
|
8000000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
|
39000000 | usd | |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14145000000 | usd |
| CY2023Q3 | us-gaap |
Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent | |
| CY2022Q4 | us-gaap |
Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent | |
| CY2022Q4 | us-gaap |
Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization | |
| CY2023Q3 | us-gaap |
Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization | |
| CY2023Q3 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent | |
| CY2022Q4 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent | |
| CY2022Q4 | us-gaap |
Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent | |
| CY2023Q3 | us-gaap |
Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent | |
| CY2023Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
381000000 | shares |
| CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
381000000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
385000000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
385000000 | shares |
| CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
|
50000000 | usd |
| CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
77000000 | usd |
| CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
52000000 | usd |
| CY2023Q3 | mrna |
Stock Repurchased During Period Including Excise Tax Value
StockRepurchasedDuringPeriodIncludingExciseTaxValue
|
1000000 | usd |
| CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3630000000 | usd |
| CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13455000000 | usd |
| CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17985000000 | usd |
| CY2022Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
11000000 | usd |
| CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
70000000 | usd |
| CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-111000000 | usd |
| CY2022Q3 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
1006000000 | usd |
| CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1043000000 | usd |
| CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17992000000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19123000000 | usd |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
19000000 | usd | |
| us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
12000000 | usd | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
226000000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
159000000 | usd | |
| us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
1153000000 | usd | |
| CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13455000000 | usd |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
31000000 | usd | |
| us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
9000000 | usd | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
164000000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-327000000 | usd | |
| us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
2927000000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
6897000000 | usd | |
| CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17992000000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-4931000000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
6897000000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
226000000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
164000000 | usd | |
| us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
419000000 | usd | |
| us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
268000000 | usd | |
| us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
41000000 | usd | |
| us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
-35000000 | usd | |
| us-gaap |
Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
|
-16000000 | usd | |
| us-gaap |
Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
|
0 | usd | |
| mrna |
Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
|
934000000 | usd | |
| mrna |
Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
|
-473000000 | usd | |
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-25000000 | usd | |
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-36000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
481000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-480000000 | usd | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-772000000 | usd | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
669000000 | usd | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-462000000 | usd | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
636000000 | usd | |
| mrna |
Increase Decrease In Right Of Use Asset Operating Leases
IncreaseDecreaseInRightOfUseAssetOperatingLeases
|
657000000 | usd | |
| mrna |
Increase Decrease In Right Of Use Asset Operating Leases
IncreaseDecreaseInRightOfUseAssetOperatingLeases
|
-29000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-8000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
89000000 | usd | |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
63000000 | usd | |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
354000000 | usd | |
| us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-1173000000 | usd | |
| us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-2691000000 | usd | |
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
8000000 | usd | |
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-810000000 | usd | |
| us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
605000000 | usd | |
| us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-27000000 | usd | |
| us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
21000000 | usd | |
| us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
273000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3740000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
3319000000 | usd | |
| us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
2097000000 | usd | |
| us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
8925000000 | usd | |
| us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
4711000000 | usd | |
| us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
2222000000 | usd | |
| us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
2725000000 | usd | |
| us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
2918000000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
487000000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
308000000 | usd | |
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
85000000 | usd | |
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | usd | |
| us-gaap |
Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
|
23000000 | usd | |
| us-gaap |
Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
|
35000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
4744000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4128000000 | usd | |
| us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
31000000 | usd | |
| us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
40000000 | usd | |
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
1153000000 | usd | |
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
2927000000 | usd | |
| mrna |
Finance Lease Principal Payments Net Of Adjustments
FinanceLeasePrincipalPaymentsNetOfAdjustments
|
146000000 | usd | |
| mrna |
Finance Lease Principal Payments Net Of Adjustments
FinanceLeasePrincipalPaymentsNetOfAdjustments
|
123000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1268000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3010000000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-264000000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3819000000 | usd | |
| CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2953000000 | usd |
| CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3041000000 | usd |
| us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
148000000 | usd | |
| us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
80000000 | usd | |
| mrna |
Right Of Use Assets Obtained Through Finance Lease Modifications And Reassessments
RightOfUseAssetsObtainedThroughFinanceLeaseModificationsAndReassessments
|
213000000 | usd | |
| mrna |
Right Of Use Assets Obtained Through Finance Lease Modifications And Reassessments
RightOfUseAssetsObtainedThroughFinanceLeaseModificationsAndReassessments
|
0 | usd | |
| us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
0 | usd | |
| us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
781000000 | usd | |
| CY2023Q3 | mrna |
Number Of Development Candidates
NumberOfDevelopmentCandidates
|
41 | candidate |
| CY2023Q3 | mrna |
Number Of Development Programs
NumberOfDevelopmentPrograms
|
43 | developmentprogram |
| CY2023Q3 | mrna |
Number Of Development Programs Under Clinical Studies
NumberOfDevelopmentProgramsUnderClinicalStudies
|
38 | developmentprogram |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
4000000 | usd |
| CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
52000000 | usd |
| CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2932000000 | usd |
| CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3027000000 | usd |
| CY2023Q3 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
17000000 | usd |
| CY2022Q3 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
0 | usd |
| CY2023Q3 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
4000000 | usd |
| CY2022Q3 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
14000000 | usd |
| CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2953000000 | usd |
| CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3041000000 | usd |
| us-gaap |
Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
|
Payment terms generally range from 30 to 60 days | ||
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
14000000 | usd |
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
1758000000 | usd |
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
254000000 | usd |
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
7402000000 | usd |
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
268000000 | usd |
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
9160000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
241000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
7635000000 | usd |
| CY2020Q2 | mrna |
Number Of Participants
NumberOfParticipants
|
30000 | participant |
| CY2023Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
4720000000 | usd |
| CY2023Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
4641000000 | usd |
| CY2023Q3 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
5462000000 | usd |
| CY2023Q3 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
5273000000 | usd |
| CY2023Q3 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
10182000000 | usd |
| CY2023Q3 | us-gaap |
Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
|
9914000000 | usd |
| CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
6792000000 | usd |
| CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
6697000000 | usd |
| CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
8687000000 | usd |
| CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
8318000000 | usd |
| CY2022Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
15479000000 | usd |
| CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
|
15015000000 | usd |
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
|
0 | usd |
| us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
|
0 | usd | |
| us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
|
0 | usd | |
| CY2022Q3 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
|
0 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | usd |
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
223000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
5524000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
464000000 | usd |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
13159000000 | usd |
| CY2023Q3 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
|
416 | security |
| CY2022Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
|
582 | security |
| CY2023Q3 | us-gaap |
Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
|
-33000000 | usd |
| us-gaap |
Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
|
-16000000 | usd | |
| CY2022Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
42000000 | usd |
| CY2023Q3 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
42000000 | usd |
| us-gaap |
Maximum Remaining Maturity Of Foreign Currency Derivatives1
MaximumRemainingMaturityOfForeignCurrencyDerivatives1
|
P15M | ||
| CY2023Q3 | us-gaap |
Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
|
0 | usd |
| CY2023Q3 | us-gaap |
Derivative Notional Amount
DerivativeNotionalAmount
|
1147000000 | usd |
| CY2023Q3 | us-gaap |
Derivative Assets
DerivativeAssets
|
7000000 | usd |
| CY2023Q3 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
12000000 | usd |
| CY2022Q4 | us-gaap |
Derivative Notional Amount
DerivativeNotionalAmount
|
1488000000 | usd |
| CY2022Q4 | us-gaap |
Derivative Assets
DerivativeAssets
|
6000000 | usd |
| CY2022Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
32000000 | usd |
| CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
0 | usd |
| CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
62000000 | usd |
| us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
0 | usd | |
| us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
|
133000000 | usd | |
| CY2023Q3 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
149000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
575000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
61000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
205000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
277000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
169000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Net
InventoryNet
|
487000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
949000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
211000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
910000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1300000000 | usd |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
1900000000 | usd | |
| CY2022Q3 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
333000000 | usd |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
1000000000 | usd | |
| CY2023Q3 | us-gaap |
Inventory Firm Purchase Commitment Loss
InventoryFirmPurchaseCommitmentLoss
|
0 | usd |
| us-gaap |
Inventory Firm Purchase Commitment Loss
InventoryFirmPurchaseCommitmentLoss
|
141000000 | usd | |
| CY2022Q3 | us-gaap |
Inventory Firm Purchase Commitment Loss
InventoryFirmPurchaseCommitmentLoss
|
7000000 | usd |
| us-gaap |
Inventory Firm Purchase Commitment Loss
InventoryFirmPurchaseCommitmentLoss
|
349000000 | usd | |
| CY2023Q3 | mrna |
Legal Contingency Future Firm Purchase Commitments
LegalContingencyFutureFirmPurchaseCommitments
|
98000000 | usd |
| CY2022Q4 | mrna |
Legal Contingency Future Firm Purchase Commitments
LegalContingencyFutureFirmPurchaseCommitments
|
268000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Gross
InventoryGross
|
698000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Gross
InventoryGross
|
1900000000 | usd |
| CY2023Q2 | us-gaap |
Other Inventory Capitalized Costs
OtherInventoryCapitalizedCosts
|
183000000 | usd |
| CY2023Q3 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
3024000000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
2676000000 | usd |
| CY2023Q3 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
1072000000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
658000000 | usd |
| CY2023Q3 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
1952000000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
2018000000 | usd |
| CY2023Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
246000000 | usd |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
414000000 | usd | |
| CY2022Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
113000000 | usd |
| us-gaap |
Other Depreciation And Amortization
OtherDepreciationAndAmortization
|
268000000 | usd | |
| CY2023Q3 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
2360000000 | usd |
| CY2022Q4 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
1385000000 | usd |
| CY2023Q3 | mrna |
Accounts Receivable Chargebacks Discounts And Fees
AccountsReceivableChargebacksDiscountsAndFees
|
-479000000 | usd |
| CY2022Q4 | mrna |
Accounts Receivable Chargebacks Discounts And Fees
AccountsReceivableChargebacksDiscountsAndFees
|
0 | usd |
| CY2023Q3 | mrna |
Accounts Receivable Allowance For Expected Credit Loss
AccountsReceivableAllowanceForExpectedCreditLoss
|
15000000 | usd |
| CY2022Q4 | mrna |
Accounts Receivable Allowance For Expected Credit Loss
AccountsReceivableAllowanceForExpectedCreditLoss
|
0 | usd |
| CY2023Q3 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
1866000000 | usd |
| CY2022Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
1385000000 | usd |
| CY2023Q3 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
210000000 | usd |
| CY2022Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
187000000 | usd |
| CY2023Q3 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
187000000 | usd |
| CY2022Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
216000000 | usd |
| CY2023Q3 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
116000000 | usd |
| CY2022Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
10000000 | usd |
| CY2023Q3 | mrna |
Other Prepaid Expense Materials And Supplies
OtherPrepaidExpenseMaterialsAndSupplies
|
61000000 | usd |
| CY2022Q4 | mrna |
Other Prepaid Expense Materials And Supplies
OtherPrepaidExpenseMaterialsAndSupplies
|
219000000 | usd |
| CY2023Q3 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
52000000 | usd |
| CY2022Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
61000000 | usd |
| CY2023Q3 | mrna |
Collaboration Receivable Current
CollaborationReceivableCurrent
|
44000000 | usd |
| CY2022Q4 | mrna |
Collaboration Receivable Current
CollaborationReceivableCurrent
|
11000000 | usd |
| CY2023Q3 | mrna |
Tenant Improvement Allowance Receivable Current
TenantImprovementAllowanceReceivableCurrent
|
42000000 | usd |
| CY2022Q4 | mrna |
Tenant Improvement Allowance Receivable Current
TenantImprovementAllowanceReceivableCurrent
|
42000000 | usd |
| CY2023Q3 | mrna |
Other Prepaid Expense Manufacturing
OtherPrepaidExpenseManufacturing
|
39000000 | usd |
| CY2022Q4 | mrna |
Other Prepaid Expense Manufacturing
OtherPrepaidExpenseManufacturing
|
229000000 | usd |
| CY2023Q3 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
26000000 | usd |
| CY2022Q4 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
140000000 | usd |
| CY2023Q3 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
0 | usd |
| CY2022Q4 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
36000000 | usd |
| CY2023Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
96000000 | usd |
| CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
44000000 | usd |
| CY2023Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
873000000 | usd |
| CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1195000000 | usd |
| CY2023Q3 | mrna |
Downpayments And Prepayments Noncurrent
DownpaymentsAndPrepaymentsNoncurrent
|
238000000 | usd |
| CY2022Q4 | mrna |
Downpayments And Prepayments Noncurrent
DownpaymentsAndPrepaymentsNoncurrent
|
0 | usd |
| CY2023Q3 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
211000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
910000000 | usd |
| CY2023Q3 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
86000000 | usd |
| CY2022Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
42000000 | usd |
| CY2023Q3 | us-gaap |
Goodwill
Goodwill
|
52000000 | usd |
| CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
0 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
45000000 | usd |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
0 | usd |
| CY2023Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
4000000 | usd |
| CY2022Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
12000000 | usd |
| CY2023Q3 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
25000000 | usd |
| CY2022Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
24000000 | usd |
| CY2023Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
661000000 | usd |
| CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
988000000 | usd |
| CY2023Q3 | mrna |
Accrued Manufacturing
AccruedManufacturing
|
779000000 | usd |
| CY2022Q4 | mrna |
Accrued Manufacturing
AccruedManufacturing
|
400000000 | usd |
| CY2023Q3 | mrna |
Accrued Clinical Trials
AccruedClinicalTrials
|
263000000 | usd |
| CY2022Q4 | mrna |
Accrued Clinical Trials
AccruedClinicalTrials
|
319000000 | usd |
| CY2023Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
251000000 | usd |
| CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
190000000 | usd |
| CY2023Q3 | us-gaap |
Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
|
184000000 | usd |
| CY2022Q4 | us-gaap |
Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
|
0 | usd |
| CY2023Q3 | mrna |
Accrued Other External Goods And Services Current
AccruedOtherExternalGoodsAndServicesCurrent
|
145000000 | usd |
| CY2022Q4 | mrna |
Accrued Other External Goods And Services Current
AccruedOtherExternalGoodsAndServicesCurrent
|
264000000 | usd |
| CY2023Q3 | mrna |
Accrued Commercial
AccruedCommercial
|
137000000 | usd |
| CY2022Q4 | mrna |
Accrued Commercial
AccruedCommercial
|
48000000 | usd |
| CY2023Q3 | mrna |
Accrued Development Operation
AccruedDevelopmentOperation
|
110000000 | usd |
| CY2022Q4 | mrna |
Accrued Development Operation
AccruedDevelopmentOperation
|
88000000 | usd |
| CY2023Q3 | mrna |
Accrued Property And Equipment Current
AccruedPropertyAndEquipmentCurrent
|
108000000 | usd |
| CY2022Q4 | mrna |
Accrued Property And Equipment Current
AccruedPropertyAndEquipmentCurrent
|
5000000 | usd |
| CY2023Q3 | mrna |
Legal Contingency Future Firm Purchase Commitments
LegalContingencyFutureFirmPurchaseCommitments
|
98000000 | usd |
| CY2022Q4 | mrna |
Legal Contingency Future Firm Purchase Commitments
LegalContingencyFutureFirmPurchaseCommitments
|
268000000 | usd |
| CY2023Q3 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
78000000 | usd |
| CY2022Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
203000000 | usd |
| CY2023Q3 | mrna |
Raw Materials Accounts Payable
RawMaterialsAccountsPayable
|
71000000 | usd |
| CY2022Q4 | mrna |
Raw Materials Accounts Payable
RawMaterialsAccountsPayable
|
316000000 | usd |
| CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2224000000 | usd |
| CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2101000000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
164000000 | usd | |
| CY2023Q3 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
150000000 | usd |
| CY2022Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
161000000 | usd |
| CY2023Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
33000000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
35000000 | usd |
| CY2023Q3 | us-gaap |
Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
|
56000000 | usd |
| CY2022Q4 | us-gaap |
Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
|
53000000 | usd |
| CY2023Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
239000000 | usd |
| CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
249000000 | usd |
| CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
2711000000 | usd |
| us-gaap |
Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
|
228000000 | usd | |
| mrna |
Contract With Customer Liability Deductions During Period
ContractWithCustomerLiabilityDeductionsDuringPeriod
|
1401000000 | usd | |
| CY2023Q3 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
1538000000 | usd |
| CY2023Q3 | mrna |
Operating Lease Number Of Properties
OperatingLeaseNumberOfProperties
|
2 | campus |
| CY2023Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
765000000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
121000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
601000000 | usd |
| CY2022Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
1150000000 | usd |
| CY2023Q3 | mrna |
Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
|
1366000000 | usd |
| CY2022Q4 | mrna |
Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
|
1271000000 | usd |
| CY2023Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
33000000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
35000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
150000000 | usd |
| CY2022Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
161000000 | usd |
| CY2023Q3 | mrna |
Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
|
183000000 | usd |
| CY2022Q4 | mrna |
Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
|
196000000 | usd |
| CY2023Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
697000000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
92000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
575000000 | usd |
| CY2022Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
912000000 | usd |
| CY2023Q3 | mrna |
Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
|
1272000000 | usd |
| CY2022Q4 | mrna |
Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
|
1004000000 | usd |
| CY2023Q3 | mrna |
Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
|
1455000000 | usd |
| CY2022Q4 | mrna |
Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
|
1200000000 | usd |
| CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
6000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
154000000 | usd |
| CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
102000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
21000000 | usd |
| CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
80000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
22000000 | usd |
| CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
82000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
23000000 | usd |
| CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
84000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
23000000 | usd |
| CY2023Q3 | mrna |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
869000000 | usd |
| CY2023Q3 | mrna |
Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
|
1097000000 | usd |
| CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1223000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
1340000000 | usd |
| CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
493000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
615000000 | usd |
| CY2023Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
730000000 | usd |
| CY2023Q3 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
725000000 | usd |
| CY2023Q3 | mrna |
Legal Contingency Future Firm Purchase Commitments
LegalContingencyFutureFirmPurchaseCommitments
|
98000000 | usd |
| CY2023Q3 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
78000000 | usd |
| us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
176000000 | usd | |
| CY2022Q3 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
106000000 | usd |
| us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
470000000 | usd | |
| CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
77000000 | usd |
| CY2022Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
70000000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
226000000 | usd | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
164000000 | usd | |
| CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
77000000 | usd |
| CY2022Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
70000000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
226000000 | usd | |
| CY2023Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
701000000 | usd |
| us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y10M24D | ||
| us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
8000000 | shares | |
| us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
143.31 | ||
| us-gaap |
Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
|
1153000000 | usd | |
| CY2023Q3 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
1667000000 | usd |
| CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1958000000 | usd |
| CY2022Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1217000000 | usd |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4012000000 | usd | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
7920000000 | usd | |
| CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1672000000 | usd |
| CY2022Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
174000000 | usd |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
919000000 | usd | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1023000000 | usd | |
| CY2023Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.855 | |
| CY2022Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.143 | |
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.229 | ||
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.129 | ||
| CY2023Q3 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1700000000 | usd |
| us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1700000000 | usd | |
| CY2023Q3 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1700000000 | usd |
| CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3630000000 | usd |
| CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1043000000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-4931000000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
6897000000 | usd | |
| CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
381000000 | shares |
| CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
390000000 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
382000000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
396000000 | shares | |
| CY2023Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
| CY2023Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
| CY2022Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
22000000 | shares |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares | |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
23000000 | shares | |
| CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
381000000 | shares |
| CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
412000000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
382000000 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
419000000 | shares | |
| CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-9.53 | |
| CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.67 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-12.89 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
17.41 | ||
| CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-9.53 | |
| CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.53 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-12.89 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
16.46 | ||
| CY2023Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
28000000 | shares |
| CY2022Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4000000 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
28000000 | shares | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3000000 | shares | |
| CY2023Q3 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
| CY2023Q3 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |
